Ding Dale, Yen Chun-Po, Starke Robert M, Xu Zhiyuan, Sun Xingwen, Sheehan Jason P
Department of Neurological Surgery, University of Virginia , Charlottesville, VA , USA.
Br J Neurosurg. 2014 Oct;28(5):666-74. doi: 10.3109/02688697.2013.872227. Epub 2013 Dec 27.
The management of Spetzler-Martin Grade-IV and -V arteriovenous malformations (AVMs) is controversial due to their uncertain natural history, the high rate of morbidity and mortality associated with microsurgical resection, and the relatively low rate of successful obliteration from less invasive approaches such as radiosurgery and embolization. We present our radiosurgical results for high-grade AVMs.
We identified all patients with Spetzler-Martin Grade-IV and -V AVMs treated with single-session radiosurgery at the University of Virginia between 1989 and 2009. Patients with less than 2 years of follow-up without obliteration were excluded. This yielded 110 patients with a median age 27.6 years. The median AVM volume was 5.7 cc and prescription dose was 19 Gy. The median radiographic and clinical follow-up intervals were 88 and 97 months, respectively.
Complete AVM obliteration was identified on MRI only in 11 patients (10%) and confirmed by DSA in 38 patients (34%) for a cumulative obliteration rate of 44%. The actuarial rates of obliteration at 3 and 5 years were 10% and 23%, respectively. The mean and median times to obliteration were 60 months and 43 months, respectively. Significant independent predictors of obliteration were no pre-radiosurgery embolization (P = 0.008), superficial location (P = 0.001), and higher prescription dose (P = 0.028). The annual rate of post-radiosurgery hemorrhage was 3.0%, and symptomatic RIC was observed in 12% of patients. Unruptured AVMs were more likely to have RIC (P = 0.005). The rates of temporary and permanent post-radiosurgery clinical deterioration were 9% and 10%, respectively.
Single-session radiosurgery is an acceptable treatment option for select patients harboring high-grade AVMs for which microsurgery or conservative management are associated with an unacceptably high risk of adverse outcomes.
Spetzler-MartinⅣ级和Ⅴ级动静脉畸形(AVM)的治疗存在争议,这是由于其自然病史不确定、与显微手术切除相关的高发病率和死亡率,以及诸如放射外科和栓塞等侵入性较小的方法导致的相对较低的完全闭塞率。我们展示了我们对高级别AVM的放射外科治疗结果。
我们确定了1989年至2009年间在弗吉尼亚大学接受单次放射外科治疗的所有Spetzler-MartinⅣ级和Ⅴ级AVM患者。随访时间少于2年且未完全闭塞的患者被排除。这产生了110例患者,中位年龄27.6岁。AVM中位体积为5.7立方厘米,处方剂量为19 Gy。放射影像学和临床随访的中位间隔时间分别为88个月和97个月。
仅在11例患者(10%)的MRI上发现AVM完全闭塞,38例患者(34%)经DSA证实,累计闭塞率为44%。3年和5年的实际闭塞率分别为10%和23%。闭塞的平均时间和中位时间分别为60个月和43个月。闭塞的显著独立预测因素是放射外科治疗前未进行栓塞(P = 0.008)、表浅位置(P = 0.001)和较高的处方剂量(P = 0.028)。放射外科治疗后每年的出血率为3.0%,12%的患者出现有症状的放射性损伤并发症(RIC)。未破裂的AVM更有可能出现RIC(P = 0.005)。放射外科治疗后暂时和永久性临床恶化的发生率分别为9%和10%。
对于某些患有高级别AVM的患者,单次放射外科治疗是一种可接受的治疗选择,对于这些患者,显微手术或保守治疗会带来不可接受的高不良结局风险。